과제정보
연구 과제 주관 기관 : National Research Foundation of Korea (NRF)
참고문헌
- Tsokos GC. Systemic lupus erythematosus. N Engl J Med 2011;365:2110-2121. https://doi.org/10.1056/NEJMra1100359
- Tsokos GC, Lo MS, Costa Reis P, Sullivan KE. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol 2016;12:716-730. https://doi.org/10.1038/nrrheum.2016.186
- Kim JM, Park SH, Kim HY, Kwok SK. A plasmacytoid dendritic cells-type I interferon axis is critically implicated in the pathogenesis of systemic lupus erythematosus. Int J Mol Sci 2015;16:14158-14170. https://doi.org/10.3390/ijms160614158
- Moulton VR, Suarez-Fueyo A, Meidan E, Li H, Mizui M, Tsokos GC. Pathogenesis of human systemic lupus erythematosus: a cellular perspective. Trends Mol Med 2017;23:615-635. https://doi.org/10.1016/j.molmed.2017.05.006
- Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet 2014;384:1878-1888. https://doi.org/10.1016/S0140-6736(14)60128-8
- Crispin JC, Liossis SN, Kis-Toth K, et al. Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol Med 2010;16:47-57. https://doi.org/10.1016/j.molmed.2009.12.005
- Merrill JT, Neuwelt CM, Wallace DJ, et al. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double- blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum 2010;62:222-233. https://doi.org/10.1002/art.27233
- Rovin BH, Furie R, Latinis K, et al. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study. Arthritis Rheum 2012;64:1215-1226. https://doi.org/10.1002/art.34359
- Ge Y, Jiang C, Sung SS, et al. Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex-mediated acute lupus glomerulonephritis. J Exp Med 2013;210:2387-2401. https://doi.org/10.1084/jem.20130731
- Yurasov S, Tiller T, Tsuiji M, et al. Persistent expression of autoantibodies in SLE patients in remission. J Exp Med 2006;203:2255-2261. https://doi.org/10.1084/jem.20061446
- Perico L, Conti S, Benigni A, Remuzzi G. Podocyte-actin dynamics in health and disease. Nat Rev Nephrol 2016;12:692-710.
- Xia H, Bao W, Shi S. Innate immune activity in glomerular podocytes. Front Immunol 2017;8:122.
- Kurts C, Panzer U, Anders HJ, Rees AJ. The immune system and kidney disease: basic concepts and clinical implications. Nat Rev Immunol 2013;13:738-753. https://doi.org/10.1038/nri3523
- Reiser J, von Gersdorff G, Loos M, et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 2004;113:1390-1397. https://doi.org/10.1172/JCI20402
- Coers W, Brouwer E, Vos JT, et al. Podocyte expression of MHC class I and II and intercellular adhesion molecule-1 (ICAM-1) in experimental pauci-immune crescentic glomerulonephritis. Clin Exp Immunol 1994;98:279-286.
- Akilesh S, Huber TB, Wu H, et al. Podocytes use FcRn to clear IgG from the glomerular basement membrane. Proc Natl Acad Sci U S A 2008;105:967-972. https://doi.org/10.1073/pnas.0711515105
- Banas MC, Banas B, Hudkins KL, et al. TLR4 links podocytes with the innate immune system to mediate glomerular injury. J Am Soc Nephrol 2008;19:704-713. https://doi.org/10.1681/ASN.2007040395
- Tanji N, Markowitz GS, Fu C, et al. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J Am Soc Nephrol 2000;11:1656-1666.
- Guo J, Ananthakrishnan R, Qu W, et al. RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis. J Am Soc Nephrol 2008;19:961-972. https://doi.org/10.1681/ASN.2007101109
- Goto K, Kaneko Y, Sato Y, et al. Leptin deficiency down-regulates IL-23 production in glomerular podocytes resulting in an attenuated immune response in nephrotoxic serum nephritis. Int Immunol 2016;28:197-208. https://doi.org/10.1093/intimm/dxv067
- Fu R, Guo C, Wang S, et al. Podocyte activation of NLRP3 inflammasomes contributes to the development of proteinuria in lupus nephritis. Arthritis Rheumatol 2017;69:1636-1646.
- Ichinose K, Ushigusa T, Nishino A, et al. Lupus nephritis IgG induction of calcium/calmodulin-dependent protein kinase IV expression in podocytes and alteration of their function. Arthritis Rheumatol 2016;68:944-952. https://doi.org/10.1002/art.39499
- Zhang C, Boini KM, Xia M, et al. Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia. Hypertension 2012;60:154-162. https://doi.org/10.1161/HYPERTENSIONAHA.111.189688
- Papadimitraki ED, Tzardi M, Bertsias G, Sotsiou E, Boumpas DT. Glomerular expression of toll-like receptor- 9 in lupus nephritis but not in normal kidneys: implications for the amplification of the inflammatory response. Lupus 2009;18:831-835. https://doi.org/10.1177/0961203309103054
- Lee SJ, Borsting E, Decleves AE, Singh P, Cunard R. Podocytes express IL-6 and lipocalin 2/ neutrophil gelatinase-associated lipocalin in lipopolysaccharide-induced acute glomerular injury. Nephron Exp Nephrol 2012;121:e86-e96. https://doi.org/10.1159/000345151
- Goldwich A, Burkard M, Olke M, et al. Podocytes are nonhematopoietic professional antigen-presenting cells. J Am Soc Nephrol 2013;24:906-916. https://doi.org/10.1681/ASN.2012020133
- Suarez-Fueyo A, Bradley SJ, Klatzmann D, Tsokos GC. T cells and autoimmune kidney disease. Nat Rev Nephrol 2017;13:329-343. https://doi.org/10.1038/nrneph.2017.34
- Wang Y, Yu F, Song D, Wang SX, Zhao MH. Podocyte involvement in lupus nephritis based on the 2003 ISN/RPS system: a large cohort study from a single centre. Rheumatology (Oxford) 2014;53:1235-1244. https://doi.org/10.1093/rheumatology/ket491
- Ikuma D, Hiromura K, Kajiyama H, et al. The correlation of urinary podocytes and podocalyxin with histological features of lupus nephritis. Lupus 2018;27:484-493. https://doi.org/10.1177/0961203317734918
- Dos Santos M, Poletti PT, Milhoransa P, Monticielo OA, Veronese FV. Unraveling the podocyte injury in lupus nephritis: clinical and experimental approaches. Semin Arthritis Rheum 2017;46:632-641. https://doi.org/10.1016/j.semarthrit.2016.10.005
- Schlondorff D, Banas B. The mesangial cell revisited: no cell is an island. J Am Soc Nephrol 2009;20:1179-1187. https://doi.org/10.1681/ASN.2008050549
- Ka SM, Cheng CW, Shui HA, et al. Mesangial cells of lupus- prone mice are sensitive to chemokine production. Arthritis Res Ther 2007;9:R67. https://doi.org/10.1186/ar2226
- Flur K, Allam R, Zecher D, et al. Viral RNA induces type I interferon-dependent cytokine release and cell death in mesangial cells via melanoma-differentiation-associated gene-5: implications for viral infection-associated glomerulonephritis. Am J Pathol 2009;175:2014-2022. https://doi.org/10.2353/ajpath.2009.080585
- Patole PS, Pawar RD, Lech M, et al. Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice. Nephrol Dial Transplant 2006;21:3062-3073. https://doi.org/10.1093/ndt/gfl336
- Fairhurst AM, Xie C, Fu Y, et al. Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis. J Immunol 2009;183:6831-6838. https://doi.org/10.4049/jimmunol.0900742
- Yung S, Cheung KF, Zhang Q, Chan TM. Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis. J Am Soc Nephrol 2010;21:1912-1927. https://doi.org/10.1681/ASN.2009080805
- Yung S, Chan TM. Anti-dsDNA antibodies and resident renal cells: their putative roles in pathogenesis of renal lesions in lupus nephritis. Clin Immunol 2017;185:40-50. https://doi.org/10.1016/j.clim.2016.09.002
- Ichinose K, Rauen T, Juang YT, et al. Cutting edge: calcium/ calmodulin-dependent protein kinase type IV is essential for mesangial cell proliferation and lupus nephritis. J Immunol 2011;187:5500-5504. https://doi.org/10.4049/jimmunol.1102357
- Tsantikos E, Maxwell MJ, Putoczki T, et al. Interleukin- 6 trans-signaling exacerbates inflammation and renal pathology in lupus-prone mice. Arthritis Rheum 2013;65:2691-2702.
- Ryffel B, Car BD, Gunn H, Roman D, Hiestand P, Mihatsch MJ. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice. Am J Pathol 1994;144:927-937.
- Castellano G, Cafiero C, Divella C, et al. Local synthesis of interferon-alpha in lupus nephritis is associated with type I interferons signature and LMP7 induction in renal tubular epithelial cells. Arthritis Res Ther 2015;17:72. https://doi.org/10.1186/s13075-015-0588-3
- Schwarting A, Relle M, Meineck M, et al. Renal tubular epithelial cell-derived BAFF expression mediates kidney damage and correlates with activity of proliferative lupus nephritis in mouse and men. Lupus 2018;27:243-256. https://doi.org/10.1177/0961203317717083
- Chen Y, Yang C, Xie Z, et al. Expression of the novel co-stimulatory molecule B7-H4 by renal tubular epithelial cells. Kidney Int 2006;70:2092-2099. https://doi.org/10.1038/sj.ki.5001867
- Yung S, Tsang RC, Sun Y, Leung JK, Chan TM. Effect of human anti-DNA antibodies on proximal renal tubular epithelial cell cytokine expression: implications on tubulointerstitial inflammation in lupus nephritis. J Am Soc Nephrol 2005;16:3281-3294. https://doi.org/10.1681/ASN.2004110917
피인용 문헌
- Role of tumor necrosis factor-like weak inducer of apoptosis/ fibroblast growth factor-inducible molecule 14 pathway in lupus nephritis vol.45, pp.4, 2018, https://doi.org/10.4103/err.err_14_18
- Altered levels of immune-regulatory microRNAs in plasma samples of patients with lupus nephritis vol.8, pp.3, 2018, https://doi.org/10.15171/bi.2018.20
- Sjögren’s syndrome and systemic lupus erythematosus: links and risks vol.11, pp.None, 2019, https://doi.org/10.2147/oarrr.s167783
- The role of microbiota in the pathogenesis of lupus: Dose it impact lupus nephritis? vol.139, pp.None, 2018, https://doi.org/10.1016/j.phrs.2018.11.023
- Autoreactive B cells in SLE, villains or innocent bystanders? vol.292, pp.1, 2018, https://doi.org/10.1111/imr.12815
- Toll-Like Receptor as a Potential Biomarker in Renal Diseases vol.21, pp.18, 2018, https://doi.org/10.3390/ijms21186712
- Diagnostic value of TWEAK for predicting active lupus nephritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis vol.43, pp.1, 2018, https://doi.org/10.1080/0886022x.2020.1853568
- Bicalutamide Exhibits Potential to Damage Kidney via Destroying Complex I and Affecting Mitochondrial Dynamics vol.11, pp.1, 2022, https://doi.org/10.3390/jcm11010135